Timo Minssen

Professor

JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- timo.minssen@jur.ku.dk
- https://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631
Mobil: +46708607517

ORCID: 0000-0002-3286-4888

Alle

121 - 130 ud af 413Pr. side: 10

Sortering: Type

Deltagelse i workshop, seminar og kursus
LES Scandinavia Annual Meeting 2019
Minssen, Timo (Inviteret foredragsholder)
23 sep. 2019
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
LES Scandinavia Perspectives on Rights Holders’ Daily Challenges
Minssen, Timo (Taler)
1 feb. 2012
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Legal challenges related to the new ESS and MAX IV facilities- meeting with the leadership of the European Spallation Source
Minssen, Timo (Arrangør)
7 nov. 2013
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Lessons learned, Lessons forgotten? - Webinar on Pandemic Preparedness
Minssen, Timo (Arrangør) & Kianzad, Behrang (Arrangør)
8 jun. 2023
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Making precision medicine a global reality by recognising the stakes of LMIC: Reflections from India (Seminar with Dr. Kshitij Kumar Singh).
Corrales Compagnucci, Marcelo (Arrangør) & Minssen, Timo (Arrangør)
24 maj 2022
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Market Distortions, Intellectual Property and Standards from an EU Perspective
Minssen, Timo (Deltager)
25 nov. 2013
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Max Planck meeting & Interview with Japanese Patent Attorney
Minssen, Timo (Deltager)
21 jan. 2018 → 22 jan. 2018
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Medical Devices and legal issues at the interface of regulation, protection and Innovation”
Minssen, Timo (Arrangør)
16 jan. 2023
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Meeting of the Nordic Intellectual Property Law Network
Minssen, Timo (Deltager)
22 maj 2009 → 24 maj 2009
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus
Nordic Meeting of Researchers in Competition Law
Minssen, Timo (Deltager)
3 okt. 2013 → 4 okt. 2013
Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Deltagelse i workshop, seminar og kursus

Forrige 1...9 10 11 12 13 14 15 16 ...42 Næste

ID: 16150437

Det Juridiske Fakultet

Timo Minssen

JUR Center for Advanced Studies in Bioscience Innovation Law

LES Scandinavia Annual Meeting 2019

LES Scandinavia Perspectives on Rights Holders’ Daily Challenges

Legal challenges related to the new ESS and MAX IV facilities- meeting with the leadership of the European Spallation Source

Lessons learned, Lessons forgotten? - Webinar on Pandemic Preparedness

Making precision medicine a global reality by recognising the stakes of LMIC: Reflections from India (Seminar with Dr. Kshitij Kumar Singh).

Market Distortions, Intellectual Property and Standards from an EU Perspective

Max Planck meeting & Interview with Japanese Patent Attorney

Medical Devices and legal issues at the interface of regulation, protection and Innovation”

Meeting of the Nordic Intellectual Property Law Network

Nordic Meeting of Researchers in Competition Law

Flest downloads

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa

The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa